a standing ovation for daraxonrasib at asco. over 40k oncologists, entrepreneurs, investors, and patient advocates together celebrating revmed's breakthru in the fight against pancreatic cancer. u never forget these moments. it's what innovation is all about.
@FidelisAurelius Very true
Some stellar bios from last year
I owned Krys and sold early
Traded Rvmd too and got scared prior to data!
Binaries tend to scare me!
$celc
This is what intrigues me about celcuity
We have data in a few days with potential of 14 -15 months mpfs making this drug one of the best out there
More importantly, drug approval getting close so I am not sure how we are trading at $130 with imminent data and approval
3/ ASCO June2, PDUFA July17. The mutant data being positive means docs dont even need to check for the mutation, except for prognosis. I suspect docs will Rx mutant pts in July when drug approved, so this will jump start the launch.
36K Followers 1K FollowingCombining investing experience, data driven strategy and AI to invest. All opinions are my own. I post my reseach and ideas. Please do your own research.
22 Followers 233 FollowingFull time trader. Check out my site for my daily market updates and sign up for a free 7 day trial for access to my premium tools and content.
167 Followers 611 FollowingSekretariatschef, Dansk Offshore. Tweeter mest om energi og klima. Tlf: 4119 9163. mail: [email protected] retweet ikke nødvendigvis enig.
95 Followers 214 FollowingBiotech 25 years. Capitalist always. Socialism is Cancer. Kicked off X for not liking Socialism. I guess I will stick to Biotech. Live n Learn. Now just Lurking
15K Followers 3K FollowingPresident & ClO at Baskin WeaIth Management. Baskin WeaIth or l may own stock mentioned in tweets. None of this is advice - do your own work!
10K Followers 355 FollowingBiotech investor. Tend to focus on contrarian names, so I'm probably buying what you are selling/hating on. All tweets are my opinions only.
310 Followers 474 FollowingDisclosure: My tweets and other activites on Twitter are not investment advice and should not be construed as such. Do your own due diligence always.
84 Followers 2K FollowingI invest in biotechs. I often tweet about companies I have positions in. Nothing I say should be considered investment advice.